Wnt inhibition promotes vascular specification of embryonic cardiac progenitors by Reichman, David E. et al.
Title Wnt inhibition promotes vascular specification of embryoniccardiac progenitors
Author(s)
Reichman, David E.; Park, Laura; Man, Limor; Redmond,
David; Chao, Kenny; Harvey, Richard P.; Taketo, Makoto M.;





© 2018. Published by The Company of Biologists Ltd. This is
an Open Access article distributed under the terms of the
Creative Commons Attribution License
(http://creativecommons.org/licenses/by/3.0), which permits
unrestricted use, distribution and reproduction in any medium




HUMAN DEVELOPMENT RESEARCH ARTICLE
Wnt inhibition promotes vascular specification of embryonic
cardiac progenitors
David E. Reichman1, Laura Park1, Limor Man1, David Redmond2, Kenny Chao1, Richard P. Harvey3,4,5,
Makoto M. Taketo6, Zev Rosenwaks1 and Daylon James1,7,*
ABSTRACT
Several studies have demonstrated a multiphasic role for Wnt
signaling during embryonic cardiogenesis and developed protocols
that enrich for cardiac derivatives during in vitro differentiation of
human pluripotent stem cells (hPSCs). However, few studies have
investigated the role of Wnt signaling in the specification of cardiac
progenitor cells (CPCs) toward downstream fates. Using transgenic
mice and hPSCs, we tracked endothelial cells (ECs) that originated
from CPCs expressing NKX2.5. Analysis of EC-fated CPCs at
discrete phenotypic milestones during hPSC differentiation identified
reduced Wnt activity as a hallmark of EC specification, and the
enforced activation or inhibition of Wnt reduced or increased,
respectively, the degree of vascular commitment within the CPC
population during both hPSC differentiation and mouse
embryogenesis. Wnt5a, which has been shown to exert an
inhibitory influence on Wnt signaling during cardiac development,
was dynamically expressed during vascular commitment of hPSC-
derived CPCs, and ectopic Wnt5a promoted vascular specification of
hPSC-derived and mouse embryonic CPCs.
KEY WORDS: Cardiac development, Cardiac differentiation, Wound
healing, Myocardial infarction, Myocardial scar formation,
Endothelial differentiation, Human embryonic stem cells,
Cardiovascular progenitor, Wnt signaling, Non-canonical Wnt,
Wnt5a, Mouse
INTRODUCTION
One out of every three deaths in the USA results from
cardiovascular disease (Roger et al., 2012). Despite the epidemic
scale of predisposing conditions (hypertension, smoking, obesity),
major advances in the surgical treatment of cardiovascular disease
have plateaued. Regenerative therapies represent a promising
alternative to surgical and/or pharmacological interventions for
cardiovascular disease, but wound healing mechanisms unique to
the heart undermine the restorative contribution of endogenous or
exogenous cells (Cleutjens et al., 1999). Autologous, tissue-resident
cardiac progenitor cells (CPCs) have demonstrated modest benefit
upon transplantation into patients following myocardial infarction
(MI) (Bolli et al., 2011; Chugh et al., 2012), and cardiomyocytes
differentiated from human pluripotent stem cells (hPSCs) and
transplanted into small animal models of MI have shown favorable
results (Laflamme et al., 2007; Shiba et al., 2012). However, non-
fatal ventricular arrhythmias have been noted in non-human
primates engrafted with hPSC-derived cardiomyocytes (Chong
et al., 2014), underscoring the challenge of achieving ordered
intercalation of exogenous cells into injured cardiac tissue.
Redirection of cardiac wound healing processes in adult hearts
might be a favorable approach for improving cardiac function
following ischemic injury. Adult zebrafish and neonatal mice are
capable of undergoing constructive heart regeneration (Uygur and
Lee, 2016), and recapitulation of these processes to redirect cell fate
could promote more constructive, pro-angiogenic wound healing.
Indeed, recent work has demonstrated the potential of this approach
in mouse models of cardiac ischemia (Zangi et al., 2013), and other
studies have identified novel mediators of cardiac regenerative
processes that might be exploited in injured heart. Yet, relatively
little is known of the signaling pathways that drive vascular fate
within the CPC population in embryogenesis or adulthood.
Among the signal transduction pathways that play a prominent role
in cardiac development and differentiation, theWnt pathway has been
extensively studied. Since early experiments in chick (Marvin et al.,
2001) and frog (Schneider andMercola, 2001) showed that inhibition
ofWnt is necessary for induction of cardiogenesis, many groups have
confirmed that naturally occurring and synthetic Wnt inhibitors can
drive the differentiation of NKX2.5+ populations in mouse embryos
and pluripotent stem cell cultures (Elliott et al., 2011; Lian et al.,
2012; Naito et al., 2006; Paige et al., 2010; Qyang et al., 2007;
Willems et al., 2011). Collectively, these studies have demonstrated
a multiphasic role for Wnt signaling in cardiac fate choice
determination (Gessert and Kuhl, 2010): activation of Wnt is
required during gastrulation for induction of cardiac mesoderm,
while inhibition of Wnt signaling later enables differentiation of
cardiac progenitors. Recent studies have demonstrated a further role
for canonical Wnt signaling in the specification of epicardial
progenitor cells from NKX2.5+ precursors (Iyer et al., 2016; Witty
et al., 2014); however, few studies have specifically addressed the role
of Wnt signaling in the designation of endothelial cell (EC) fate;
GSK3β inhibitors have been used in chemically defined medium to
robustly induce differentiation of CD34+ CD31 (PECAM1)+
endothelial progenitors from hPSCs (Bao et al., 2015; Lian et al.,
2014), and a high-content screening assay identified numerous
pharmacological inhibitors of Wnt that promoted the differentiation
of cardiomyocytes, and no other mesodermal derivative, from hPSCsReceived 25 September 2017; Accepted 26 November 2017
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(Willems et al., 2011). Yet these studies incorporated Wnt inhibition
into heterogeneous cultures of differentiating hPSCs during a
relatively early and/or broad temporal window. As such, the
function of Wnt specifically in the designation of cardiac EC,
myocardial, smooth muscle or fibroblast fate from multipotent CPCs
remains unclear.
Here, we have generated a dual reporting hPSC line that identifies
NKX2.5+ (cardiac) and VE-cadherin (CDH5)+ (endothelial)
derivatives during differentiation. Utilizing this line and a cross of
vascular [Flk1-GFP (Ema et al., 2006)] and cardiac [Nkx2.5Cre
(Stanley et al., 2002)] mouse reporter strains, we specifically
identified and tracked ECs that originated from cardiac progenitors
in vitro and in vivo. Expression analysis and live monitoring of Wnt
activity during hPSC differentiation and in vivo cardiogenesis
revealed a correlation between reduced Wnt activity and acquisition
of EC identity, and inhibition of Wnt signaling promoted vascular
specification of hPSC-derived andmouse embryonic CPCs. Finally,
gain-of-function experiments in hPSC cultures and mouse embryos
revealed a function for WNT5A, the non-canonical Wnt effector, in
the vascular specification of CPCs. These data elucidate a novel
influence on EC specification from cardiac-specific progenitors and
identify Wnt signal inhibition via WNT5A as a potential driver of
neovascularization in the developing heart.
RESULTS
Demarcation of vascular commitment from NKX2.5-
expressing hPSC derivatives
To enable live tracking and longitudinal analysis of cardiac and
endothelial fate acquisition in an experimentally tractable in vitro
model, we applied an EC-specific transgenic labeling strategy based
on the CDH5 promoter [VPr (James et al., 2010)] to the cardiac-
specific hPSC line NKX2.5eGFP/w (Elliott et al., 2011) (Fig. 1A).
Differentiation of this line in conditions that promote cardiovascular
cell fate (Lian et al., 2012; Paige et al., 2010; Willems et al., 2011)
resulted in regions in which both reporters were enriched (Fig. 1B),
and flow cytometry corroborated the presence of NKX2.5GFP+ ECs.
Indeed, live tracking of hPSC differentiation over 48 h from day 8 to
10 revealed a progressive decrease in single-positive NKX2.5GFP+
VPrneg cells as the double-positive NKX2.5GFP+ VPrmOrange+
population increased (Fig. 1C-E, Movies 1,2). This approach
enabled the live tracking and analysis of three unique populations
via microscopy and flow cytometry: NKX2.5+ VPrneg CD31neg
cardiac progenitors/cardiomyocytes (CP/CM, green); NKX2.5+
VPr+ CD31+ ECs (NkxEC, red); and NKX2.5neg VPr+ CD31+ ECs
that no longer express NKX2.5 or never did (nECs, blue) (Fig. 1F).
Nkx2.5-expressing progenitors contribute significantly to
endocardial ECs
To establish a complementary lineage-tracing strategy in the mouse
that specifically distinguishes ECs that arise from Nkx2.5-expressing
(NkxEC) versus non-Nkx2.5-expressing (nEC) compartments, we
crossed Flk1-GFP mice (Ema et al., 2006) with RosatdTom (Madisen
et al., 2010) andNkx2.5Cre (Stanley et al., 2002) strains. NkxECswere
observed in the cardiac crescent (Fig. 2A) and endocardium
(Fig. 2B), and made up a large proportion of endocardial ECs in
sections of embryonic day (E) 11.5 heart (Fig. 2C), with
colocalization masking (spatial overlap of cardiac and vascular-
specific reporter signals) in respective cardiac chambers revealing an
increased ratio of NkxECs in ventricles (Fig. 2D). To determine
whether NkxECs are present in other organs during development, we
isolated organs at E12.5 and enzymatically dissociated them into
single-cell suspensions. Flow cytometry revealed a substantial
population of tdTom+ cells in liver and lung; however, the NkxEC
population was exclusively observed in the heart (Fig. 2E).
RNA-sequencing (RNA-seq) of NkxECs reveals reduced Wnt
activation and a tip cell phenotype
Resolution of hPSC derivatives precisely at the interface of CPC and
NkxEC fate enables identification of candidate signaling pathways
that might play an inductive role in vascular specification within the
heart. To define molecular hallmarks that are unique to NkxECs and
identify signaling pathways that play a role in the specification of
endocardial fate, we compared RNA-seq profiles of human
umbilical vein ECs (HUVECs) with that of CP/CMs, NkxECs
and nECs at day 7 of differentiation (Fig. 3). Three biological
replicates of each population were isolated by FACS for RNA
isolation and sequencing and an expressionMDS plot revealed clear
differentiation between all four populations (Fig. 3A), with direct
comparison of NkxECs with nECs revealing the unique character
of NkxECs. Among the top 100 genes upregulated in NkxECs
(Fig. 3B) were numerous genes that have been linked to Notch
signaling/tip cell phenotype (del Toro et al., 2010). Additionally,
among transcripts known to be related to Wnt signaling (KEGG
database), CP/CMs were highly enriched for targets of canonical
Wnt (arrowheads, Fig. 3C) as well as canonical and non-canonical
inhibitors (asterisks, Fig. 3C), all of which were significantly
reduced upon acquisition of NkxEC fate.
Enforced Wnt inhibition promotes NkxEC fate from hPSC-
derived CPCs
To address the role of Wnt during vascular commitment of hPSC-
derived CPCs, we augmented published protocols for cardiovascular
differentiation by extending 2 days of Wnt inhibition to 5 days
(Fig. 4A). Relative to control conditions, prolonged Wnt inhibition
promoted an increased proportion of NkxECs and total ECs at the
expense of CP/CMs (Fig. 4B,C). To isolate the effect of Wnt signal
inhibition on the NKX2.5-expressing progenitor population, we
purified CP/CMs by FACS at day 7 and exposed them to
pharmacological modulators of Wnt signaling in escalating
concentrations (Fig. 4D). Inhibition (Endo-IWR1) or activation
(CHIR99021) of Wnt signaling increased or decreased, respectively,
the percentage of ECs within the CP/CM-derived population. An
alternative inhibitor of Wnt signaling, XAV-939, also increased the
percentage of ECs arising from isolated CP/CMs (Fig. 4E).
The gold standard for demonstration of multipotency and lineage
selection in cell culture is isolation and tracking of single-cell clones.
To test the effect of Wnt signal inhibition at a clonal level, we
distributed CP/CMs at serial dilution into culture conditions in which
Wnt signaling was activated or inhibited (Fig. 4F,G). FACS deposition
(seeMaterials andMethods) resulted in clonal outgrowths from 10.2%
and 8.6% of cells isolated from day 7 (Fig. 4F) and 10 (Fig. 4G) of
differentiation, respectively, and these cells were split into three groups
that were cultured in medium containing VEGFA alone or combined
with CHIR99021 or Endo-IWR1. After 6 days, clonal outgrowths
were assessed for EC content. The percentage of clones containing
ECs was significantly lower for CP/CMs isolated at day 10, perhaps
reflecting a reduced volume of CPCs within the CP/CM population at
later stages. Importantly, the percentage of clones that contained ECs
was lower following Wnt activation at either time point, and although
the percentage of EC-containing clones was only slightly increased
following Wnt inhibition, it is possible that plating cells at clonal
density effectively eliminates the paracrine signaling impetus present
inmulticellular culture, resulting in de factoWnt inhibition under these
conditions.
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Cardiac-specific gain/loss of Wnt function modulates
vascular fate in vivo
To determine whether Wnt signaling is linked to cardiac EC
specification in vivo, we crossed TCF/Lef:H2B-GFP mice (Ferrer-
Vaquer et al., 2010), which provide single-cell resolution of Wnt
signaling status, with a strain carrying an EC-specific Cre
recombinase [VEC-Cre (Chen et al., 2009), referred to here as
Cdh5Cre] and RosatdTom (Madisen et al., 2010). Within the cardiac
crescent of these embryos at ∼E8.0 (Fig. 5A), Wnt was variably
activated; however, nascent ECs were uniformly negative for H2B-
GFP, apart from rare cells (arrow, Fig. 5A) in which H2B-GFP was
faintly observed. Wnt activation and EC identity were also mutually
exclusive upon establishment of endocardial ECs at E8.5 (Fig. 5B)
and later in ECs within the ventricles of the E11.5 heart (Fig. 5C).
To measure the effect of cardiac-specific gain or loss of Wnt
function on the NkxEC:nEC ratio, we crossed Flk1-GFP;Nkx2.5Cre;
RosatdTom mice with Ctnnb1Exon3 mice (Harada et al., 1999)
(β-cateninGOF) and Ctnnb1flox/flox mice (Brault et al., 2001)
(β-cateninLOF). At E11.5, β-cateninLOF embryos were grossly
normal, but showed malformed atria, reduced ventricular cell
density and septal defects (Fig. 5D,E, Movie 3). Quantification of
EC volume in cryosections revealed an increased percentage of
NkxECs in the right ventricle (Fig. 5F). β-cateninGOF embryos were
grossly aberrant at E11.5 (Movie 4) and clear differences relative to
control littermates began to manifest at E9.0, with affected embryos
exhibiting smaller size, defective heart looping and reduced vascular
density within the heart (Fig. 5G, Movies 5,6). In contrast to the
increased percentage of NkxECs present in β-cateninLOF hearts,
β-cateninGOF hearts showed the reverse trend beginning at E9.0, with
a significantly reduced total EC number and proportion of NkxECs in
ventricles, atria and outflow tract of looping hearts (Fig. 5H).
Non-canonicalWnts promote vascular specificationof hPSC-
derived CP/CMs
In search of physiological influences that govern vascular
specification within the heart, we examined global transcriptional
analysis of NkxECs. In addition to downstream targets of Wnt
activation, the two major ligands that mediate a non-canonical
inhibitory influence on Wnt signaling, WNT5A and WNT11, were
enriched in CP/CMs (Fig. 3C). Based on these datawe hypothesized
that non-canonical paracrine signaling elaborated by the expanding
pool of CP/CMs might function to inhibit Wnt activation, thereby
Fig. 1. Demarcation of vascular
commitment from NKX2.5-expressing
hPSC derivatives. (A) The NKX2.5eGFP/w
hPSC line was targeted with lentiviral
particles encoding VPrmOrange, an EC-
specific promoter sequence driving mOrange
fluorescent protein. (B) Following 10 days of
serum-free differentiation, a colony of hPSC
derivatives was scanned by confocal
microscopy. Boxed regions are shown at
higher magnification to the right. Arrows
indicate endothelial cells that are also GFP
positive. Arrowheads indicate cells that are
single positive for the NKX2.5-GFP reporter.
(C-E) Live images of differentiation cultures
were captured in sequential time-lapse
culture from days 8 to 10; representative
populations isolated from differentiation at
day 10 are shown (D) and quantification of
NKX2.5+ VPrneg (green), NKX2.5neg VPr+
(blue) and NKX2.5+ VPr+ (red) pixel density is
shown (E). Coloc, colocalization. (F) Dual
reporting hPSCs enable identification of
unique populations that represent successive
stages in the developmental hierarchy of
cardiac endothelial specification. Scale bars:
B, 100 µm; D, 1 mm.
3











balancing proliferation with vascular specification. To test this, we
FACS isolated CP/CMs at day 6 and cultured them in the presence
of recombinant WNT5A and WNT11. Similarly to Endo-IWR1,
CP/CMs cultured with WNT5A and WNT11 generated
significantly increased CD31+ ECs at the expense of NKX2.5+
CD31neg derivatives at 3 and 6 days post isolation (Fig. 6A,B).
Supporting the inhibitory effect of these non-canonical ligands on
Wnt activation status, CP/CMs transduced with a lentiviral reporter
based on the Wnt-responsive TCF/Lef promoter element exhibited a
decrease in activity in the presence of WNT5A and WNT11 that was
comparable to that caused by Endo-IWR1 (Fig. 6C). Expansion of
CP/CM-derived ECs in the presence of WNT5A and Wnt11 did not
occur via proliferative expansion, as CellTracker reagent introduced
into CP/CMs upon their isolation was retained at levels equal to that
of the control (Fig. 6D). However, surface expression of FLK1 was
increased in response to WNT5A, resulting in increased mean
fluorescence intensity of signal in resultant ECs (Fig. 6E,F). Finally,
knockdown of endogenous WNT5A via lentiviral shRNA during
hPSC differentiation (Fig. 6G) decreased the percentage of total ECs
among differentiated derivatives (Fig. 6H), while increasing the yield
of CP/CMs at the expense of NkxECs within the NKX2.5GFP+
population (Fig. 6I).
Wnt5a gain of function enhances vascular specification of
Nkx2.5-expressing CPCs
To elaborate on in vivo gain- and loss-of-function experiments
(Fig. 5) and assess the role of non-canonical Wnt signaling in
directing vascular fate of CPCs, we crossed Flk1-GFP;Nkx2.5Cre;
RosatdTom mice with the Igs1tm6(CAG-Bgeo,-Wnt5a)Nat (Wnt5aGOF; see
Materials and Methods) andWnt5aflox/flox (Ryu et al., 2013) strains,
enabling constitutive expression or deletion of Wnt5a in Nkx2.5-
expressing cells and their derivatives (Fig. 7). Live-born pups
containing Nkx2.5Cre and Wnt5aGOF or Wnt5aflox/flox alleles were
not observed (data not shown). Examination of E12.5 Flk1-GFP;
Nkx2.5Cre;RosatdTom;Wnt5aGOF embryos revealed malformed atria,
reduced ventricular cell density and septal defects (Fig. 7A,Movie 7).
Quantification of ECs via colocalization masking in the ventricles
of mutant versus wild-type littermates revealed an increased ratio of
NkxECs in Wnt5aGOF hearts (Fig. 7B), whereas the incidence of
mitotic cells in Wnt5aGOF hearts was reduced (Fig. 7C). Notably,
Flk1-GFP;Nkx2.5Cre;RosatdTom;Wnt5aflox/flox analyzed at E13.5 also
exhibited septal defects and aberrant development of the right
ventricle (Fig. 7D), but the relative enrichment of NkxECs observed
in the context of Wnt5aGOF was reversed (Fig. 7E). However, the
reduction in NkxECs in ventricles of Wnt5aflox/flox hearts was not
significant and proliferation was not affected (Fig. 7F), suggesting
potential compensation for loss of Wnt5a by the closely related
Wnt11.
DISCUSSION
Owing to the multiphasic influence of the Wnt pathway during
embryogenesis, as well as the diversity of signaling modulators that
function during development, clearly defining the role of Wnt at
each milestone of cardiogenesis presents a major challenge. Here,
we interrogated the role of the Wnt pathway in specifying
endothelial derivatives of embryonic CPCs and demonstrated a
Fig. 2. Nkx2.5-expressing progenitors contribute
significantly to endocardial ECs. (A,B) Flk1-GFP;
Nkx2.5Cre;RosatdTom mouse embryos were isolated
at E7.75 (A) and E8.5 (B), enabling specific
identification of cells derived from Nkx2.5-expressing
progenitors (red) and ECs (green). In B, arrows
indicate myocardium and arrowheads indicate
endocardium. (C,D) Cryosections of E11.5 heart with
colocalization masking enabling quantification of the
NkxEC:nEC ratio. (E) Organs isolated from Flk1-
GFP;Nkx2.5Cre;RosatdTom embryos at E12.5 were
dissociated and the distribution of NkxECs (green)
and CD45+ cells (blue) was quantified within the
tdTomato+ population (red). LA, left atrium; LV, left
ventricle; RA, right atrium; RV, right ventricle; Nuc,
nuclei staining. Scale bars: 100 µm.
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Fig. 3. See next page for legend.
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differential influence of Wnt signaling in regulating the growth and
vascular specification of CPCs during mouse cardiogenesis and
cardiac differentiation of hPSCs. By combining recombinase-based
fate mapping and cardiac-specific perturbations of Wnt signaling
with in vitro modulation of Wnt signaling in hPSC differentiation
cultures, we linked inhibition of Wnt signaling with acquisition of
vascular fate, and identified a novel mechanism of cardiac
neovascularization that is mediated by paracrine modulation of
Wnt signaling in CPCs (Fig. 8).
The cellular origins of the coronary vasculature and its
developmental patterning are relatively unexplored areas that have
important implications for treatment of cardiovascular disease.
Although endocardium has previously been thought to provide
negligible contribution to myocardial vessels (Ishii et al., 2009),
numerous groups have since demonstrated that endocardium
undergoes angiogenic sprouting to generate endothelial networks
within the coronary vascular tree (Del Monte and Harvey, 2012;Wu
et al., 2012; Zhang and Zhou, 2013). Indeed, endocardial ECs in the
fetal human heart have been shown to exhibit tip cell behavior, with
endothelial networks in the myocardium sprouting from
endocardial progenitors (Rusu et al., 2015). Therefore, increased
expression of transcripts related to Notch signaling and tip cell
phenotype in hPSC-derived NkxECs (Fig. 3B) might derive from an
angiogenic impetus that is native to endocardium. Notch is known
to provide a unique regulatory input in endothelial tip cells during
neoangiogenesis (Benedito et al., 2009), and precise temporal
regulation of Notch signaling between endocardium and
myocardium coordinates ventricular patterning with coronary
vessel development (D’Amato et al., 2016). Application of hPSC-
derived endocardium in cell-based in vitro models of endocardial/
myocardial crosstalk might provide a means of dissecting
mechanisms of cardiac neovascularization and repair.
Although few studies have examined the effect of Wnt signal
modulation on vascular specification of CPCs, pan-EC
recombination strategies using Tie2-Cre and Cdh5-Cre mice have
examined the effect of EC-specific gain/loss of β-catenin function
(Corada et al., 2010). Although these mutations are not specifically
targeted to heart vasculature, Corada et al. (2010) attributed the
lethal phenotype of β-cateninGOF embryos to increased Notch signal
activation, which has been shown to reduce expression of Flk1
(Vegfr2 or Kdr) (Suchting et al., 2007; Williams et al., 2006). Given
the essential role of Notch in tip cells during neoangiogenesis
(Benedito et al., 2009), increased expression of tip cell genes in
NkxECs (Fig. 3B) might reflect a role for Notch during vascular
specification of CP/CMs. Indeed, Flk1 is an essential mediator of
EC identity and absolutely required for acquisition of EC fate
(Shalaby et al., 1997), so Wnt crosstalk with Flk1 via Notch could
indirectly influence vascular specification of CP/CMs. Lower levels
of FLK1 in CP/CMs cultured with CHIR99021 (Fig. 6E) and
increased FLK1 in response to WNT5A or WNT11 (Fig. 6F) are
Fig. 3. RNA-seq of NkxECs reveals reduced Wnt activation and tip cell
phenotype. (A) RNA-seq was performed on biological triplicate samples of
HUVECs, CP/CMs, NkxECs and nECs; an expressionMDS plot showing clear
differentiation between the four cell types is shown. (B) Heatmap showing the
top 100 genes that were upregulated in NkxECs relative to nECs. (C) Heatmap
showing a KEGG list of Wnt pathway components with transcripts listed
according to log fold change (FC) of CP/CMs over NkxECs. Asterisks
(B) specify genes known to be highly expressed in endothelial tip cells or
(C) specify Wnt effectors known to play an inhibitory function. Arrowheads
(C) specify canonical Wnt target genes. P<1×10−5 for all transcripts in B; the
dashed boxes (C) shows transcripts that are significantly increased (upper) or
decreased (lower) in CP/CMs relative to NkxECs (P<0.05).
Fig. 4. Enforced Wnt inhibition promotes NkxEC fate
from hPSC-derived CPCs. (A-C) hPSCs were
sequentially stimulated with factors that promote
cardiovascular differentiation with the Wnt inhibitor Endo-
IWR1 included for 2 days (days 2-4) or for an extended
period (days 2-7). Colored contour plots showing
representative flow cytometry measurements of the two
conditions at day 7 (B) and quantification of the CP/CM,
NkxEC and nEC populations (C). (D) CP/CMs were
isolated at day 7 of differentiation and cultured for an
additional 5 days in different concentrations of Endo-IWR1
or CHIR99021. The percentage of CD31+ cells in resultant
cultures was determined by flow cytometry. (E) Day 7 CP/
CMs were isolated and cultured in increasing
concentrations of the Wnt inhibitor XAV-939. The
percentage of CD31+ cells was quantified after 5 days.
(F,G) CP/CMs were isolated at day 7 (F) or 10 (G) of
differentiation and plated at clonal density. Clones
exhibiting the presence of EC derivatives after 6 days were
quantified in response to control, CHIR99021 or Endo-
IWR1 conditions. Error bars represent s.d. between eight
(C) or six (D,E) biological replicates or (F,G) between three
groups of clones with the aggregate number of clones for
all three groups shown beneath the bar. *P<0.05,
**P<0.01, relative to control conditions.
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consistent with an influence of Wnt signal activation on FLK1 in
hPSC-derived CP/CMs. However, further experiments will be
required to precisely define the mechanistic link between Wnt,
Notch and FLK1 at the interface of CPC and EC identity.
Multiple studies have investigated the effect of β-catenin gain/
loss of function during murine cardiogenesis (Klaus et al., 2007;
Kwon et al., 2007). These studies revealed the multiphasic nature of
Wnt, with loss of β-catenin later in cardiogenesis resulting in
diminished right ventricles (derived from second heart field),
whereas left ventricles (derived from first heart field) are of normal
size. β-cateninLOF embryos described in the present study (Fig. 5D-F)
recapitulated previously reported anatomical aberrations, but also
displayed a shift in the NkxEC:nEC ratio toward NkxECs
specifically in the right ventricle. Distinct EC subgroups within
the embryonic heart are difficult to parse, as they are believed to
arise from multiple populations, including pharyngeal mesoderm
and progenitors within the first and second heart fields (Harris and
Black, 2010; Vincent and Buckingham, 2010). Our measurements
of EC ratio during mouse cardiogenesis identified a substantial
contribution of both NkxECs and nECs to endocardium; however,
NkxECs were relatively enriched in the left ventricle (derived
primarily from first heart field). Combined with the fact that
conditional ablation of β-catenin significantly increased the
proportion of NkxECs only in the left ventricle, these data
suggest that Nkx2.5-expressing progenitors make a more
substantial contribution to left ventricular endocardium. A
shortcoming of this study is the lack of correlative Cre-based
strains that enable manipulation of the nEC compartment. However,
the finding that Wnt5a gain of function increased the proportion of
NkxECs in both ventricles suggests that Wnt inhibition via secreted
non-canonical ligands amplifies specification of NkxECs and not
nECs from their respective progenitor populations. This could stem
from a differential response to Wnt signaling among EC-competent
progenitors or could be due to the fact that nECs may originate from
progenitors that have undergone vascular specification outside the
region of Wnt5a expression.
Previous studies have demonstrated a requirement for Wnt5a and
Wnt11 in cardiac development (Bisson et al., 2015; Cohen et al.,
2012), and both ligands exert an inhibitory influence on Wnt
signaling in cells expressing the receptor Ror2 (van Amerongen et al.,
2012). Wnt5a expression has also been linked to β-catenin-mediated
Wnt activation in epicardium: knockout of Wt1 results in reduced
expression of Wnt5a as well as β-catenin targets (von Gise et al.,
2011); and Wnt activation is accompanied by upregulation of Wnt5a
in transient fibrotic tissue that ultimately gives rise to regenerated
cardiomyocytes following cryoinjury of neonatal heart (Mizutani
et al., 2016). In the present study, inhibitory effectors of canonical and
non-canonical Wnt signaling were significantly enriched in CP/CMs
(Fig. 2B,C), and exposure to exogenous WNT5A and WNT11 in
isolated CP/CMs, or ectopic Wnt5a in embryonic mouse heart,
Fig. 5. Cardiac-specific gain/loss of Wnt
functionmodulates vascular fate in vivo.
(A-C) Whole-mount confocal images of
TCF/Lef:H2B-GFP;Cdh5Cre;RosatdTom
mouse embryos at E8.0 (A) and E8.5 (B)
and isolated heart at E11.5 (C).
Arrowheads (A-C) indicate ECs; arrows
indicate (A) an EC that is faintly positive for
TCF/Lef:H2B-GFP or (B,C) TCF/Lef:H2B-
GFP+ cells. (D,E) The β-cateninLOF strain
was crossed with Flk1-GFP;Nkx2.5Cre;
RosatdTom mice to generate embryos with
heterozygous and homozygous ablation of
β-catenin. z-stack projections are
compared (D) and sagittal and coronal
sections are shown (E). (F) The percentage
of NkxECs was quantified for the left and
right ventricles of β-cateninLOF versus
heterozygous littermates. Error bars
represent s.d. between five biological
replicates. *P<0.05. (G,H) β-cateninGOF
males were crossed with Flk1-GFP;
Nkx2.5Cre;RosatdTom females to generate
embryos with constitutively active Wnt
signaling in the heart. β-cateninGOF
embryos versus control littermates are
shown at E9.0 and E9.5 (G) and total EC
number and percentage NkxECs were
measured for ventricles, atria and outflow
tract of β-cateninGOF versus control
littermate hearts between E8.5 and E9.5
(H). Scale bars: A-E,G, 100 µm.
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enriched for NkxECs (Fig. 5). Although a vascular phenotype in
embryonic hearts of Wnt5a and/or Wnt11 mutant mice has not been
addressed, the data above suggest that non-canonicalWnt plays a role
in not only morphogenesis and proliferation, but also vascular
specification within embryonic heart.
Although there is no precedent for Wnt activation regulating
FLK1 expression in CPCs, recent work has expanded the scope of
Wnt signaling during cardiogenesis, elucidating its function in
balancing the differentiation and proliferation of epicardial
progenitor-like cells from hPSCs (Iyer et al., 2016; Witty et al.,
2014). These studies demonstrate a transient growth phase
following specification of CPCs, during which cells progress
through proepicardial intermediates to self-renewing epicardial cells
that generate smooth muscle cell (SMC) and fibroblast derivatives.
Although differentiation of hPSC-derived epicardium to EC fate is
negligible and numerous studies suggest that epicardium in
development mostly contributes to cardiomyocytes, SMCs and
fibroblasts (Cai et al., 2008; Zhou et al., 2008a), fate-mapping
experiments have clearly demonstrated that the proepicardial organ
derives from Nkx2.5-expressing progenitors (Zhou et al., 2008b)
and makes a substantial contribution to the coronary vasculature
(Katz et al., 2012). Indeed, a previous study of epicardial-specific
null mutation of β-catenin demonstrated a failure of epicardial cells
to colonize and expand within the subepicardial space, ultimately
resulting in a lack of subepicardial vascularization (Zamora et al.,
2007). Given the prominent contribution that epicardium makes to
the cellular constitution of the cardiac wound healing response,
interrogation of pathways that modulate the differentiation potential
of epicardial progenitors might provide a means of improving the
recovery of functional cardiac tissue following ischemic injury.
Many groups have linked inhibition of Wnt signaling to improved
wound healing following MI. Transgenic mice overexpressing the
Wnt inhibitor SFRP1 showed reduced scar formation and improved
cardiac function following MI with significantly higher capillary
density observed in transgenic hearts (Barandon et al., 2004, 2003).
Direct administration of recombinant SFRP2 (He et al., 2010) or
SFRP4 (Matsushima et al., 2010) into the heart post-MI reduced
fibrosis and improved cardiac function in a dose-dependent manner,
resulting in better infarct healing. This benefit is recapitulated in cell-
autonomous models ofWnt loss of function: conditional depletion of
β-catenin in adult hearts following MI results in mobilization of
tissue-resident CPCs, increased 4-week survival and improved left
ventricular function (Zelarayan et al., 2008). Pharmacological
inhibition of Wnt also provides a benefit during cardiac wound
healing: Pyrvinium, an FDA-approved drug that has been shown to
exert an inhibitory influence on Wnt, improved cardiac function at 1
month post-MI (Saraswati et al., 2010), and a peptide fragment that
acts as a competitive inhibitor of Wnt signal activation (UM206)
reduced infarct size and improved cardiac function and survival
following MI, with a significant increase in neovascularization of the
infarct zone (Laeremans et al., 2011). Finally, two recent studies have
employed pharmacological inhibitors of porcupine, a protein required
to enable exit of Wnt ligands from the endoplasmic reticulum, to
demonstrate a beneficial effect of global Wnt inhibition on cardiac
remodeling and function post-MI (Bastakoty et al., 2016; Moon et al.,
2017). Although Wnt signaling is likely to play a role in numerous
pathological responses to cardiac wound healing, including
inflammation, proliferation and remodeling, these results might
reflect a capacity for Wnt signal inhibition to enforce pro-angiogenic
differentiation among adult CPCs.
MATERIALS AND METHODS
Human pluripotent stem cell (hPSC) culture
Experiments were performed using the Mel-1 NKX2.5eGFP/w hPSC line
(Elliott et al., 2011), which was provided by David Elliot, Andrew Elefanty
and Edouard Stanley. Permission for use of this cell line was granted by
the Cornell-Rockefeller-Sloan Kettering Institute ESCRO committee.
hESC culture medium consisted of Advanced DMEM/F12 (Gibco) with
20% Knockout Serum Replacement (Invitrogen), L-glutamine (2 mM,
Invitrogen), Pen/Strep (Invitrogen), β-mercaptoethanol (550 nM, Gibco),
and 4 ng/ml FGF2 (Invitrogen). hESCs were maintained on Matrigel
(Corning) using MEF-conditioned hPSC medium (GlobalStem) and
Fig. 6. Non-canonical Wnt signaling promotes vascular specification of
hPSC-derived CPCs. (A,B) The CP/CM population was isolated at day 6 and
cultured in the presence of CHIR99021, Endo-IWR1 or recombinant WNT5A
or WNT11; the total number of NKX2.5GFP+ CD31neg and CD31+ cells was
quantified after 3 (A) and 6 (B) days. (C) The CP/CM population was isolated at
day 6 of differentiation and transduced with lentiviral particles containing a
luciferase reporter driven by a TCF/Lef-based promoter; the activity of the
reporter within NKX2.5GFP+ CD31neg derivatives was measured after 4 days.
(D-F) CP/CMs were isolated at day 6 of differentiation and incubated with
CellTracker reagent to monitor cell proliferation; after 6 days in various growth
conditions, the mean fluorescent intensity of the CellTracker reagent was
measured among NKX2.5GFP+ CD31neg and CD31+ derivatives. (E,F)
Following 3 or 6 days of CP/CM culture in various conditions, the mean
fluorescent intensity of FLK1 was measured on NKX2.5GFP+ CD31neg (E) and
CD31+ (F) derivatives. (G-I) EndogenousWNT5A transcript level was reduced
in hPSCs using lentiviral shRNA (G), resulting in a reduced percentage of ECs
among hPSC derivatives (H) and a reduced proportion of ECs within the
NKX2.5GFP+ population (I). Error bars represent s.d. between six (A-F) or five
(G-I) biological replicates. *P<0.05, **P<0.01.
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handled as previously described (James et al., 2006). All cell lines were
confirmed to be mycoplasma free every ten passages.
Lentiviral transduction
Lentiviruses were generated by transfecting 15 µg lentiviral vector, 3 µg
pENV/VSV-G, 5 µg pRRE, and 2.5 µg pRSV-REV in HEK 293T cells
(passage 8-10; subconfluent, 100 mm dish) by the calcium precipitation
method. Supernatants were collected 40 and 64 h after transfection and
concentrated by Lenti-X concentrator (Clontech, 31232). Using
NKX2.5eGFP/w hPSCs, clonal lines containing the VPrmOrange EC-specific
transgene were obtained as previously described (James et al., 2011).
hPSC differentiation
One day before plating hPSCs to begin differentiation, MEF-conditioned
medium was replaced with hPSC culture medium without FGF2 and
supplemented with 2 ng/ml BMP4. The next day (day 0 of differentiation),
hPSCs were plated directly onto gelatin in hPSC culture medium (without
FGF2, plus 20 ng/ml BMP4, 40 ng/ml activin A, 2.5 µM CHIR99021) and
not disturbed for 48 h. On day 2, cells were stimulated with 40 ng/ml BMP4
and 2 ng/ml FGF2. Differentiation cultures containing VEGFA at 10 ng/ml
beginning fromday 2 to point of harvest. In isolated CP/CM cultures, VEGFA
was not included during bulk hPSC differentiation. CHIR99021, Endo-IWR1
and XAV-939 were used at 2.5 µM unless otherwise indicated. Recombinant
cytokines (Wnt5a, Wnt11; R&D Systems) were used at 100 ng/ml.
Lentivirus-based reporter assay
FACS-sorted CP/CMs were plated into individual wells of a 48-well flat-
bottom plate in hPSC base medium with 10 ng/ml VEGFA and other
recombinant cytokines as indicated. Individual wells were transduced
overnight with TCF/Lef lentiviral particles expressing firefly luciferase or
the respective positive and negative control lentiviral particles (Cignal Lenti
Reporter Kit, SABiosciences) at a multiplicity of infection of 25 according
to the manufacturer’s instructions. After 18 h, medium was removed and
CP/CMs were incubated in designated conditions for 3 days further,
changing the medium after 2 days. Four days following isolation, luciferase
activity was measured on a SpectraMax M5 microplate reader (Molecular
Devices) using the Steady-Glo Luciferase Assay System (Promega)
according to the manufacturer’s instructions.
RNA-seq library construction, sequencing and analysis
Total RNAwas prepared from FACS-sorted cells and quality was checked on
an Agilent Technologies 2100 Bioanalyzer. 1 µg high-quality total RNAwas
used as input to convert mRNA into a library of template molecules for
subsequent cluster generation and sequencing using the reagents provided in
Fig. 7. Wnt5a gain of function enhances vascular
specification of Nkx2.5-expressing CPCs. (A-C) Flk1-
GFP;Nkx2.5Cre;RosatdTom mice were crossed with the
Wnt5aGOF strain. Whole-mount and coronal views of
control and Wnt5aGOF hearts at E12.5 (A), and the
percentage of NkxECs (B) and frequency of phospho-
histone H3-positive cells per field (C) were quantified in
control and Wnt5aGOF hearts. (D-F) Flk1-GFP;Nkx2.5Cre;
RosatdTom mice were crossed with the Wnt5aflox/flox strain.
Whole-mount and coronal views of Wnt5aWT/flox and
Wnt5aflox/flox hearts at E13.5 (D), and the percentage of
NkxECs (E) and frequency of phospho-histone H3-positive
cells per field (F) were quantified in Wnt5aWT/flox and
Wnt5aflox/flox hearts. Error bars represent s.d. between five
biological replicates; in C,F counting 1 out of every 12
sections (10 µm thickness). Colocalization threshold
masks denoting NkxECs (red) and nECs (green) are
shown (A,D), with merged fluorescence images shown in
the inset. Regions within dashed boxes (A,D) are
magnified to the right. Asterisks indicate septal defects in
mutant mice. Scale bars: 100 µm.
Fig. 8. Multiphasic function of intersection of canonical and non-
canonical Wnt signaling during cardiovascular lineage diversification.
Wnt plays multiple roles during differentiation of pluripotent cells within the
cardiovascular lineage. Wnt signaling initially directs pluripotent cells toward
cardiac mesoderm, but is later inhibited during specification of cardiac
progenitor cells expressing Nkx2.5. Subsequently, inhibition of Wnt signaling
within the Nkx2.5+ pool via non-canonical Wnt5a promotes vascular
specification.
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the Illumina TruSeq RNA Sample Preparation Kit. Following purification of
the poly(A)-containing mRNA using poly(T) oligo-attached magnetic beads,
the mRNA was fragmented into small pieces using divalent cations under
elevated temperature. The cleaved RNA fragments were copied into first-
strand cDNA using reverse transcriptase and random primers, followed by
second-strand cDNA synthesis using DNA polymerase I and RNase H. These
cDNA fragments then went through an end-repair process, the addition of a
single ‘A’ base, and then ligation of adapters. The products were purified and
enriched by PCR to create the final cDNA library. After quantifying and
checking the size and purity of the product, multiplexed DNA libraries were
normalized to 10 nM and then two sample libraries were pooled together in
equal volumes. 7 pM each pooled DNA library template was amplified on an
Illumina cBot instrument, involving immobilization and 3′ extension, bridge
amplification, linearization and hybridization, then sequenced on one lane of
the Illumina HiSeq2000 sequencer using the pair-end module and generating
2×58 bp reads. The samples HUVEC, CP/CM, NkxEC and nEC were aligned
to the human GRCh38 reference assembly (NCBI) using STAR aligner
(Dobin et al., 2013) and subsequently genes were counted in htseq (Harada
et al., 1999). The raw counts mapping toGRCh38were subsequently analyzed
in R package edgeR and differential expression analysis was performed. After
selecting the most variant 910 genes by expression, multidimensional scaling
(MDS) plots were prepared among the sample groups, and showed clear
differentiation between the four tissue types (Fig. 3A).
FACS
Flow cytometry analysis and sorting was performed on a FACSJazz (BD
Biosciences). Configuration of the FACSJazz was as follows: 405 nm laser
with 450/50 band pass (BP) (DAPI) and 520/35 BP (BV 510) filters;
488 nm laser with 530/40 BP (GFP) and 585/29 BP (PE) filters; and 640 nm
laser with 660/20 BP (APC) and 750 LP (APC-Cy7) filters. Antibodies used
were specific for human CD31-PE (MEC 13.3, BD Biosciences), human
CD43-APC (10G7, Biolegend), mouse CD31-PE (390, eBioscience) and
mouse CD45-APC (30-F11, eBioscience); antibodies were used at the
concentration recommended by the manufacturer. Data were analyzed using
FACS Diva software (BD Biosciences). Clonal sorting was via direct
deposition of five cells per well of a 96-well plate using the FACSJazz
Automated Cell Deposition Unit (ACDU).
Immunofluorescence
Cells were stained as previously described (James et al., 2010). Samples
were fixed in 4% paraformaldehyde, permeabilized in PBST (0.1% Tween
20) and blocked in 5% donkey serum for 45 min. Samples were incubated
for 2 h in blocking solution containing primary antibodies that were directly
conjugated to Alexa 488, 568 or 647. Antibodies used were specific for
CD31 (MEC 13.3, BD Biosciences), Nkx2.5 (8792, Cell Signaling), cardiac
troponin (MAB6887, R&D Systems) and smooth muscle actin (MAB1420,
R&D Systems). Imaging was performed using a Zeiss LSM 710 confocal
microscope.
Confocal microscopy and live imaging
Microscopy was performed using a 710META confocal microscope (Zeiss)
with the following laser lines: 405, 458, 488, 514, 561 and 633 nm. Filter
settings for fluorescent proteins and fluorophores were: 450/20 BP for
DAPI; 530/20 BP for GFP and Alexa 488; 560/20 BP for mOrange; 630/30
BP for tdTomato; and 670/20 BP for Alexa 647. For live imaging,
NKX2.5eGFP/VPrmOrange hPSCs were cultured at 37°C and 5% CO2 in a
stage-mounted incubation chamber (Tokai Hit), with image capture at
variable intervals. Colocalization was performed using Zen colocalization
software (Zeiss) and the pixel area of single- and double-positive cells
quantified.
Mouse strains
All procedures were approved by the Institutional Animal Care and Use
Ethics Committee of Weill Cornell Medical College. Breeding was
performed using animals between 12 weeks and 1 year of age. The mouse
strains that were intercrossed to generate the animals in this study were:
Flk1-GFP (Jackson Labs, 017006), RosatdTom (Jackson Labs, 007905),
TCF:LEFH2B-GFP (Jackson Labs, 013752), Cdh5Cre (Jackson Labs, 017968),
β-cateninflox/flox (Jackson Labs, 004152), Igs1tm6(CAG-Bgeo,-Wnt5a)Nat
(Wnt5aGOF; Jackson Labs, 018141), Wnt5aflox/flox mice (Jackson Labs,
026626), Nkx2.5Cre [provided by Richard Harvey (Stanley et al., 2002)] and
β-cateninflEx3/flEx3 [provided by Makoto Taketo (Harada et al., 1999)]. For
quantification of NkxEC versus nEC number, 10 µm sections were collected
for the entire span of the heart and colocalization masking distinguished EC
subtypes.
Statistical analysis
Experiments were repeated at least three times, with the technician
performing quantitative analysis blinded to the experimental conditions.
We included all tested animals for quantification to analyze the statistical
difference. A representative image from experimental groups is presented in
corresponding figures. No statistical method was used to predetermine
sample size. Differences between groups containing more than one
condition were assessed by one-way ANOVA, and to quantify statistical
difference of each condition to control an unpaired two-tailed t-test was
performed.
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